Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dauphinée

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Clinical & Laboratory Immunology|February 1, 1979
Characteristics of peritoneal lymphocytes from New Zealand Black and normal mice autoreactive for mouse erythrocytesM Dauphinée, N Talal
Cellular Immunology|November 1, 1988
Synergistic interaction between anti-CD3 and IL-2 demonstrated by proliferative response, interferon production, and non-MHC-restricted killingZ Tovar, M Dauphinée, N Talal
Journal of the American Podiatric Medical Association|September 17, 2005
Morphological and functional changes in the diabetic peripheral nerve: using diagnostic ultrasound and neurosensory testing to select candidates for nerve decompressionDoohi Lee, Damien M Dauphinée
Arthritis and Rheumatism|May 1, 1988
B cells expressing CD5 are increased in Sjögren's syndromeM Dauphinée, Z Tovar, N Talal
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1985
[T cell sub-sets, changes in Ia-antigen positive cells and IL-2 abnormality in MRL mice, with special reference to lpr gene]N Miyasaka, M Dauphinée, M Fischbach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1977
Antigen induced alterations in splenic prostaglandin and cyclic nucleotide levels in NZB miceD R Webb, I Nowowiejski, M Dauphinée, et al.
Ostomy/Wound Management|April 7, 2010
A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeksRobert J Snyder, Matthew Cardinal, Damien M Dauphinée, et al.
Advances in Nephrology From the Necker Hospital|January 1, 1983
Interleukin-2 and autoimmune diseaseN Talal, M Dauphinée, P Christadoss, et al.
International Journal of Radiation Oncology, Biology, Physics|November 8, 2001
Five-chlorodeoxycytidine, a tumor-selective enzyme-driven radiosensitizer, effectively controls five advanced human tumors in nude miceS Greer, M Alvarez, M Mas, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Clinical & Laboratory Immunology|February 1, 1979
Characteristics of peritoneal lymphocytes from New Zealand Black and normal mice autoreactive for mouse erythrocytesM Dauphinée, N Talal
Cellular Immunology|November 1, 1988
Synergistic interaction between anti-CD3 and IL-2 demonstrated by proliferative response, interferon production, and non-MHC-restricted killingZ Tovar, M Dauphinée, N Talal
Journal of the American Podiatric Medical Association|September 17, 2005
Morphological and functional changes in the diabetic peripheral nerve: using diagnostic ultrasound and neurosensory testing to select candidates for nerve decompressionDoohi Lee, Damien M Dauphinée
Arthritis and Rheumatism|May 1, 1988
B cells expressing CD5 are increased in Sjögren's syndromeM Dauphinée, Z Tovar, N Talal
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1985
[T cell sub-sets, changes in Ia-antigen positive cells and IL-2 abnormality in MRL mice, with special reference to lpr gene]N Miyasaka, M Dauphinée, M Fischbach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1977
Antigen induced alterations in splenic prostaglandin and cyclic nucleotide levels in NZB miceD R Webb, I Nowowiejski, M Dauphinée, et al.
Ostomy/Wound Management|April 7, 2010
A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeksRobert J Snyder, Matthew Cardinal, Damien M Dauphinée, et al.
Advances in Nephrology From the Necker Hospital|January 1, 1983
Interleukin-2 and autoimmune diseaseN Talal, M Dauphinée, P Christadoss, et al.
International Journal of Radiation Oncology, Biology, Physics|November 8, 2001
Five-chlorodeoxycytidine, a tumor-selective enzyme-driven radiosensitizer, effectively controls five advanced human tumors in nude miceS Greer, M Alvarez, M Mas, et al.
Pageof 1